tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AMGN Stock Latest News

Dow Jones Index Today: UnitedHealth Drags Down DIA Stock
Market NewsDow Jones Index Today: UnitedHealth Drags Down DIA Stock
39m ago
GS
HD
Amgen price target raised to $319 from $315 at UBS
PremiumThe Fly
Amgen price target raised to $319 from $315 at UBS
3d ago
AMGN
Sandoz files antitrust litigation against Amgen regarding Enbrel
PremiumThe Fly
Sandoz files antitrust litigation against Amgen regarding Enbrel
3d ago
AMGN
Amgen says Phase 3 DeLLphi-304 trial of Imdelltra met primary endpoint
PremiumThe Fly
Amgen says Phase 3 DeLLphi-304 trial of Imdelltra met primary endpoint
6d ago
AMGN
Quantum Computing News: Quantum Firms Drive New Breakthroughs in 2025
PremiumMarket News
Quantum Computing News: Quantum Firms Drive New Breakthroughs in 2025
8d ago
HON
IBM
Morning Movers: Pharmaceuticals sink as impending tariffs seen coming
PremiumThe FlyMorning Movers: Pharmaceuticals sink as impending tariffs seen coming
8d ago
BMY
BTU
Amgen price target raised to $330 from $328 at Morgan Stanley
Premium
The Fly
Amgen price target raised to $330 from $328 at Morgan Stanley
8d ago
AMGN
Amgen announces FDA approval of Uplizna
Premium
The Fly
Amgen announces FDA approval of Uplizna
14d ago
AMGN
Amgen’s Strong Market Position and Growth Potential Justify Buy Rating
PremiumRatings
Amgen’s Strong Market Position and Growth Potential Justify Buy Rating
17d ago
AMGN
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History”
PremiumMarket News
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History”
21d ago
MRK
PFE
Quantinuum Shakes Up Quantum Computing with Giant Backers and Big Moves
PremiumMarket News
Quantinuum Shakes Up Quantum Computing with Giant Backers and Big Moves
23d ago
HON
IBM
Cathie Wood’s ARK Invest Snaps Up Tesla Stock (TSLA) amid 42% Price Drop
PremiumMarket News
Cathie Wood’s ARK Invest Snaps Up Tesla Stock (TSLA) amid 42% Price Drop
27d ago
AMGN
ARKK
BMO says Eylea court decision ‘modest negative’ for Regeneron
PremiumThe FlyBMO says Eylea court decision ‘modest negative’ for Regeneron
1M ago
AMGN
REGN
Appeals court upholds denial of Regeneron motion for injunction against Amgen
Premium
The Fly
Appeals court upholds denial of Regeneron motion for injunction against Amgen
1M ago
AMGN
REGN
Regeneron down 3% after appeals court decision in Amgen patent fight
Premium
The Fly
Regeneron down 3% after appeals court decision in Amgen patent fight
1M ago
AMGN
REGN
Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
PremiumThe Fly
Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
1M ago
AMGN
RNAC
Amgen reports new data from Phase 3 registrational MINT trial of Uplinza
PremiumThe Fly
Amgen reports new data from Phase 3 registrational MINT trial of Uplinza
1M ago
AMGN
Amgen’s Mixed Trial Results and Competitive Challenges Lead to Hold Rating
PremiumRatings
Amgen’s Mixed Trial Results and Competitive Challenges Lead to Hold Rating
1M ago
AMGN
Positive Outlook for Amgen: Buy Rating Backed by Promising Rocatinlimab and Obesity Treatment Prospects
PremiumRatings
Positive Outlook for Amgen: Buy Rating Backed by Promising Rocatinlimab and Obesity Treatment Prospects
1M ago
AMGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
BMY
ABBV
Positive Outlook for Amgen’s Stock Driven by Promising Rocatinlimab Trial Results
Premium
Ratings
Positive Outlook for Amgen’s Stock Driven by Promising Rocatinlimab Trial Results
1M ago
AMGN
Amgen’s Rocatinlimab Faces Challenges in Atopic Dermatitis Market: Hold Rating Maintained
Premium
Ratings
Amgen’s Rocatinlimab Faces Challenges in Atopic Dermatitis Market: Hold Rating Maintained
1M ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >